Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

NCT03476655 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma, Mantle-Cell

Interventions

DRUG: Ibrutinib

Sponsor

Johnson & Johnson Private Limited